NOTICE: Due to a lapse in annual appropriations, most of this website is not being updated. Learn more.
Form submissions will still be accepted but will not receive responses at this time. Sections of this site for programs using non-appropriated funds (such as NVLAP) or those that are excepted from the shutdown (such as CHIPS and NVD) will continue to be updated.
An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Development of a Candidate Secondary Reference Procedure (immunoassay based measurement procedure of higher metrological order) for Cardiac Troponin I: I. Antibody Characterization and Preliminary Validation
Published
Author(s)
James E. Noble, David M. Bunk, R. H. Christenson, Kenneth D. Cole, Hua-Jun He, Alexei Katrukha, Mauro Panteghini, Robert Porter, Heinz Schimmel, Jillian Tate, Lili Wang
Abstract
The development of a reference measurement procedure to support the cardiac troponin I (cTnI) standardization initiative is described. The reference measurement procedure will be used to assign reference values to serum-based secondary standards. A multiplexed bead-based assay and SDS-PAGE were used to identify the optimum antibody pair; clones 560 and 19C7 for the reference assay. Described is current progress on the development of the ELISA based procedure that will need to accurately measure all isoforms of cTnI present in serum. The current RMP appears to show no bias when tested with purified samples representing various troponin complexes, phosophorylated states and heparin interference. The candidate assay displays suitable linearity and sensitivity (limit of detection of 52 ng/L) for the measurement of the proposed cTnI serum standards. Limited data with patient samples and comparison with commercial analyzers is provided to support its suitability for reference value assignment. Full validation and assessment of the procedure will be determined through round-robin studies.
Noble, J.
, Bunk, D.
, Christenson, R.
, Cole, K.
, He, H.
, Katrukha, A.
, Panteghini, M.
, Porter, R.
, Schimmel, H.
, Tate, J.
and Wang, L.
(2010),
Development of a Candidate Secondary Reference Procedure (immunoassay based measurement procedure of higher metrological order) for Cardiac Troponin I: I. Antibody Characterization and Preliminary Validation, Clinical Chemistry and Laboratory Medicine
(Accessed October 17, 2025)